Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             99 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool Piñero, Federico

2 p.
artikel
2 A hepatitis B virus transgenic mouse model with a conditional, recombinant, episomal genome Kruse, Robert L.

2 p.
artikel
3 AKR1B1 drives hyperglycemia-induced metabolic reprogramming in MASLD-associated hepatocellular carcinoma Syamprasad, NP

2 p.
artikel
4 A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma Balcar, Lorenz

2 p.
artikel
5 Ascites control by TIPS is more successful in patients with a lower paracentesis frequency and is associated with improved survival Piecha, Felix
2019
2 p. 90-98
artikel
6 Assessing physician preferences on future therapeutic options and diagnostic practices in non-alcoholic steatohepatitis Cook, Nigel

2 p.
artikel
7 Assessing the periprocedural magnitude of platelet count change in response to lusutrombopag Brown Jr., Robert S.

2 p.
artikel
8 Association of HBsAg levels with differential gene expression in NK, CD8 T, and memory B cells in treated patients with chronic HBV Beudeker, Boris J.B.

2 p.
artikel
9 Autoantibody formation against a canalicular epitope found in a patient with acute intrahepatic cholestasis with PFIC-like presentation Schumacher, Jonas

2 p.
artikel
10 Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis Wirtz, Theresa H.

2 p.
artikel
11 Bile acid-receptor TGR5 deficiency worsens liver injury in alcohol-fed mice by inducing intestinal microbiota dysbiosis Spatz, Madeleine

2 p.
artikel
12 Biliary disease progression in childhood onset autoimmune liver disease: A 30-year follow-up into adulthood Warner, Suz

2 p.
artikel
13 Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicine Leiting, Jennifer L.

2 p.
artikel
14 Case-finding strategies in non-alcoholic fatty liver disease Boursier, Jerome

2 p.
artikel
15 Cell of origin in biliary tract cancers and clinical implications Moeini, Agrin

2 p.
artikel
16 Chemotherapy-induced recruitment of myeloid-derived suppressor cells abrogates efficacy of immune checkpoint blockade Kwong, Tsz Tung

2 p.
artikel
17 Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer Loosen, Sven H.

2 p.
artikel
18 Comment on “Quality of life and unmet needs in patients with chronic liver disease: A mixed-method systematic review” Valery, Patricia Casarolli

2 p.
artikel
19 Comparison of the current international guidelines on the management of HCC Foerster, Friedrich
2019
2 p. 114-119
artikel
20 Contents 2019
2 p. iii
artikel
21 Contents
2 p.
artikel
22 Contents
2 p.
artikel
23 Contents
2 p.
artikel
24 Contents
2 p.
artikel
25 Contents
2 p.
artikel
26 Continuous terlipressin infusion is associated with improved diet intake and muscle strength in patients awaiting liver transplant Chapman, Brooke
2019
2 p. 107-113
artikel
27 Copyright and Information 2019
2 p. e1
artikel
28 Copyright and information
2 p.
artikel
29 Copyright and information
2 p.
artikel
30 Copyright and information
2 p.
artikel
31 Copyright and information
2 p.
artikel
32 Copyright and information
2 p.
artikel
33 Editorial Board 2019
2 p. i
artikel
34 Editorial Board
2 p.
artikel
35 Editorial Board page
2 p.
artikel
36 Editorial Board page
2 p.
artikel
37 Editorial Board page
2 p.
artikel
38 Editorial Board page
2 p.
artikel
39 Editorial musings Sherman, Morris
2019
2 p. iv-v
artikel
40 Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2 Kudo, Masatoshi

2 p.
artikel
41 Effects of a reorganization of cirrhosis care during the lockdown for SARS-CoV-2 outbreak Piano, Salvatore

2 p.
artikel
42 Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance Sacherl, Julia

2 p.
artikel
43 Emerging roles of circular RNAs in liver cancer Louis, Corentin

2 p.
artikel
44 European ‘NAFLD Preparedness Index’ — Is Europe ready to meet the challenge of fatty liver disease? Lazarus, Jeffrey V.

2 p.
artikel
45 Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosis Vidal-González, Judit

2 p.
artikel
46 Extended hypothermic oxygenated machine perfusion enables ex situ preservation of porcine livers for up to 24 hours Brüggenwirth, Isabel M.A.

2 p.
artikel
47 Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT study Kolligs, Frank

2 p.
artikel
48 From congestive hepatopathy to hepatocellular carcinoma, how can we improve patient management? Sessa, Anna

2 p.
artikel
49 Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency Felzen, Antonia

2 p.
artikel
50 Global progress on the elimination of viral hepatitis as a major public health threat: An analysis of WHO Member State responses 2017 Smith, Shanley
2019
2 p. 81-89
artikel
51 Gut dysbiosis as a driver in alcohol-induced liver injury Fairfield, Bradley

2 p.
artikel
52 Health inequalities in the management of chronic hepatitis B virus infection in patients from sub-Saharan Africa in high-income countries Mitchell, Tim

2 p.
artikel
53 Hepatitis B and C screening needs among different ethnic groups: A population-based study in Amsterdam, the Netherlands Zuure, Freke
2019
2 p. 71-80
artikel
54 Higher phenolic acid intake independently associates with lower prevalence of insulin resistance and non-alcoholic fatty liver disease Salomone, Federico

2 p.
artikel
55 Hospice care utilisation among elderly patients who died with hepatocellular carcinoma in the United States de Avila, Victor

2 p.
artikel
56 Humoral immunity in hepatitis B virus infection: Rehabilitating the B in HBV Vanwolleghem, Thomas

2 p.
artikel
57 Impact of waiting time on post-transplant survival for recipients with hepatocellular carcinoma: A natural experiment randomized by blood group Beumer, Berend R

2 p.
artikel
58 Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection Wu, Hui-Chen

2 p.
artikel
59 Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance Johnson, Katherine

2 p.
artikel
60 Ketamine restriction correlates with reduced cholestatic liver injury and improved outcomes in critically ill patients with burn injury De Tymowski, Christian

2 p.
artikel
61 Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis Shepherd, Emma L.

2 p.
artikel
62 Limitations of non-invasive tests for assessment of liver fibrosis Patel, Keyur

2 p.
artikel
63 Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD Akbari, Camilla

2 p.
artikel
64 Low-phospholipid-associated cholelithiasis syndrome: Prevalence, clinical features, and comorbidities Dong, Catherine

2 p.
artikel
65 Low sphingolipid levels predict poor survival in patients with alcohol-related liver disease Kronborg, Thit Mynster

2 p.
artikel
66 Metabolic reprogramming of hepatocytes by Schistosoma mansoni eggs von Bülow, Verena

2 p.
artikel
67 miR-22 inhibition reduces hepatic steatosis via FGF21 and FGFR1 induction Hu, Ying

2 p.
artikel
68 Modelling HDV kinetics under the entry inhibitor bulevirtide suggests the existence of two HDV-infected cell populations Shekhtman, Louis

2 p.
artikel
69 Myosteatosis: Diagnosis, pathophysiology and consequences in metabolic dysfunction-associated steatotic liver disease Henin, Guillaume

2 p.
artikel
70 NAFLD and MAFLD as emerging causes of HCC: A populational study Myers, Shuna

2 p.
artikel
71 NASH-related increases in plasma bile acid levels depend on insulin resistance Grzych, Guillaume

2 p.
artikel
72 Non-alcoholic fatty liver disease does not increase dementia risk although histology data might improve risk prediction Shang, Ying

2 p.
artikel
73 O-GlcNAc transferase acts as a critical nutritional node for the control of liver homeostasis Ortega-Prieto, Paula

2 p.
artikel
74 Prevention of lipid droplet accumulation by DGAT1 inhibition ameliorates sepsis-induced liver injury and inflammation Teixeira, Lívia

2 p.
artikel
75 Primary liver cancer in the UK: Incidence, incidence-based mortality, and survival by subtype, sex, and nation Burton, Anya

2 p.
artikel
76 Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failure Blaya, Delia

2 p.
artikel
77 Radiotherapy for HCC: Ready for prime time? Bang, Andrew
2019
2 p. 131-137
artikel
78 Rates, patterns, and predictors of specialty palliative care consultation among patients with acute-on-chronic liver failure Patel, Arpan

2 p.
artikel
79 Rationale of adding muscle volume to muscle fat infiltration in the definition of an adverse muscle composition is unclear Nachit, Maxime

2 p.
artikel
80 Real-world experience with obeticholic acid in patients with primary biliary cholangitis D’Amato, Daphne

2 p.
artikel
81 Reply to: “Comment on “Quality of life and unmet needs in patients with chronic liver disease: A mixed-method systematic review”” Grønkjær, Lea Ladegaard

2 p.
artikel
82 Reply to: "Rationale of adding muscle volume to muscle fat infiltration in the definition of an adverse muscle composition is unclear" Linge, Jennifer

2 p.
artikel
83 Roles of innate lymphoid cells in metabolic and alcohol-associated liver diseases Bourinet, Manon

2 p.
artikel
84 Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection Janssen, Harry L.

2 p.
artikel
85 Spatial characterisation of β-catenin-mutated hepatocellular adenoma subtypes by proteomic profiling of the tumour rim Di Tommaso, Sylvaine

2 p.
artikel
86 Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease Jiao, Jingjing

2 p.
artikel
87 Spleen stiffness to liver stiffness ratio significantly differs between ALD and HCV and predicts disease-specific complications Elshaarawy, Omar
2019
2 p. 99-106
artikel
88 Stellate cell expression of SPARC-related modular calcium-binding protein 2 is associated with human non-alcoholic fatty liver disease severity Larsen, Frederik T.

2 p.
artikel
89 TGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overload Bidault-Jourdainne, Valeska

2 p.
artikel
90 The oncogenic role of hepatitis delta virus in hepatocellular carcinoma Puigvehí, Marc
2019
2 p. 120-130
artikel
91 The second volume Sherman, Morris

2 p.
artikel
92 The third year Sherman, Morris

2 p.
artikel
93 Transforming growth factor β latency: A mechanism of cytokine storage and signalling regulation in liver homeostasis and disease Li, Yujia

2 p.
artikel
94 Transplant oncology – Current indications and strategies to advance the field Krendl, Felix J.

2 p.
artikel
95 Vasoconstrictor antagonism improves functional and structural vascular alterations and liver damage in rats with early NAFLD van der Graaff, Denise

2 p.
artikel
96 Where are the children in national hepatitis C policies? A global review of national strategic plans and guidelines Malik, Farihah

2 p.
artikel
97 Whole blood RNA sequencing identifies transcriptional differences between primary sclerosing cholangitis and ulcerative colitis Wacker, Eike Matthias

2 p.
artikel
98 90Y-/166Ho- ‘Radiation lobectomy’ for liver tumors induces abnormal morphology and impaired drainage of peritumor lymphatics Andel, Daan

2 p.
artikel
99 ZBTB20 regulates WNT/CTNNB1 signalling pathway by suppressing PPARG during hepatocellular carcinoma tumourigenesis To, Jeffrey C.

2 p.
artikel
                             99 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland